Review
Published on 14 Feb 2023
Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1111393
- 5,835 views
- 7 citations
Type at least 3 characters
580 articles
Articles
Review
Published on 13 Feb 2023
What is the need and why is it time for innovative models for understanding lung repair and regeneration?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1130074
- 2,934 views
- 3 citations
Original Research
Published on 10 Feb 2023
Ferroptosis-related genes are involved in asthma and regulate the immune microenvironment
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1087557
- 6,453 views
- 11 citations
Original Research
Published on 03 Feb 2023
Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1089812
- 3,697 views
- 10 citations
Original Research
Published on 30 Jan 2023
Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1064307
- 2,439 views
- 2 citations
Clinical Trial
Published on 19 Jan 2023
Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1092748
- 2,182 views
- 1 citation
Editorial
Published on 16 Jan 2023
Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1037610
- 1,299 views
Mini Review
Published on 13 Jan 2023
Open questions in human lung organoid research
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1083017
- 5,539 views
- 5 citations
Original Research
Published on 12 Jan 2023
Fast cycling of intermittent hypoxia in a physiomimetic 3D environment: A novel tool for the study of the parenchymal effects of sleep apnea
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1081345
- 1,915 views
Original Research
Published on 09 Jan 2023
Dang Gui Bu Xue Tang, a conventional Chinese herb decoction, ameliorates radiation-induced heart disease via Nrf2/HMGB1 pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1086206
- 2,449 views
- 4 citations
Original Research
Published on 06 Jan 2023
Tetramethylpyrazine ameliorates acute lung injury by regulating the Rac1/LIMK1 signaling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1005014
- 3,206 views
- 8 citations
Original Research
Published on 06 Jan 2023
Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1070736
- 2,443 views
- 10 citations
Correction
Published on 04 Jan 2023
Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1036927
- 1,074 views
- 1 citation
Original Research
Published on 22 Dec 2022
FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1019755
- 3,686 views
- 5 citations
Correction
Published on 16 Dec 2022
Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1117317
- 981 views
Review
Published on 12 Dec 2022
Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1033043
- 3,215 views
- 1 citation